In vitro assays

Researcher in a medical lab
#Contract Research Organisations (CROs) #Drug discovery #In vitro assays #Toxicology

CN Bio introduces cross-species DILI services

CN Bio has introduced two new animal microphysiological system (MPS) models to its contract research services (CRS) that it hopes will enhance translatability in preclinical drug safety and toxicology assessments.  Building upon its drug induced liver injury (DILI) assay, the company says the expanded offering enables rapid, comparative studies between… Read More

#Business & Investment #News

Heart in a box
#3D cell culture #Advertorial #Biosafety testing #Cell Science #In vitro assays

Ncyte Heart in a Box: Human iPSC-derived 3D cardiac microtissue

This advertorial for Ncardia appeared in DDW Volume 26 – Issue 2, Spring 2025 Read the digital issue When hearts are on the line, accuracy is vital.  Ncyte® Heart in a Box™ is a high-purity, high-functional cell product that mirrors the human heart’s complexity in vitro, giving you a physiologically… Read More

#Exclusive Content

TEM micrograph of kidney proximal tubule cells
#Drug development #Drug discovery #Drug toxicity #eBook #In vitro #In vitro assays

eBook: A guide to predictive in vitro renal proximal tubule models

This latest eBook provides a comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies. The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics… Read More

#News

#Drug development #Drug discovery #Drug toxicity #In vitro #In vitro assays

Your comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies

The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics and how to measure mitochondrial health… Read More

#Resources

#App note #CNS #In vitro #In vitro assays #iPSC #Neuroscience

App Note: Optimisation for a live cell in vitro neuronal activity assay

Human induced pluripotent stem cell (iPSC) derived models are increasingly being used for in vitro studies of the human central nervous system. Growth factors and cytokines are critical in these models for cell growth, differentiation, and survival, but their study is complicated by factors like unknown commercial media compositions and… Read More

#News

#In vitro #In vitro assays #iPSC #Neuroscience

Development of robust co-culture models with human iPSC-derived microglia and excitatory neurons

Download this Application Note to learn more about: Co-culture methods for ioMicroglia with wild type and disease model ioGlutamatergic Neurons. Assay optimisation for a live cell in vitro neuronal activity assay. Solutions for visualisation and quantification of changes in co-culture health, morphology, function and marker expression. Read More

#Resources

#Assay development optimisation & technology #Assay validation #Assays #Cellular assays #In vitro assays

Assays: A key ingredient to success in drug discovery

DDW’s Megan Thomas discusses the value of assays and their influence across the drug discovery sector. Assays are a critical part of drug discovery, providing various means to measure biological or biochemical activity of potential drug compounds. Across the sector, it is evident the impact they have and their inherent… Read More

#Exclusive Content

Scientist using a well plate
#Automated workflows #Cell culture #Drug discovery #In vitro assays #minit #Semarion

Early adopters get access to new microcarrier platform

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory, has opened the Early Adopter Programme for its SemaCyte Microcarrier Platform. The platform aims to overcome the limitations associated with adherent cell culture and assaying workflows by enabling small colonies of cells to be moved… Read More

#News

Neurons in the brain
#Drug discovery #In vitro assays #Multiple sclerosis #Neurodegenerative disorders #Neuronal damage #Target identification #Webinar

Webinar: Innovative assays for neurodegeneration drug discovery

Neurodegenerative diseases are characterised by neuronal damage, degradation of the blood-brain barrier and failures in the normal repair mechanisms of the brain. Many of the most promising areas of drug development in this field target neuroinflammation and remyelination. In this new on-demand webinar we use multiple sclerosis as a case-study… Read More

Webinar date:
Brought to you by Malvern Panalytical
#News

Neurons in the brain
#Drug discovery #In vitro assays #Multiple sclerosis #Neurodegenerative disorders #Neuronal damage #Target identification #Webinar

Innovative assays for neurodegeneration drug discovery programs

Neurodegenerative diseases are characterised by neuronal damage, degradation of the blood-brain barrier and failures in the normal repair mechanisms of the brain. Many of the most promising areas of drug development in this field target neuroinflammation and remyelination. In this on-demand webinar, presented by Dr Elise Malavasi, Principal Scientist at… Read More

Webinar date:
Brought to you by Malvern Panalytical
#Webinars